Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 CAD | 0.00% |
|
-6.25% | +15.38% |
06-26 | Transcript : MediPharm Labs Corp. - Shareholder/Analyst Call | |
06-20 | MediPharm Labs Acquires Rights for Advanced Medical Cannabis Products From Remidose Aerosols | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 22.19M | |
+26.93% | 5.55B | |
-33.55% | 3.52B | |
-3.74% | 3.03B | |
-26.09% | 2.59B | |
-10.93% | 2.28B | |
+41.50% | 1.88B | |
+41.84% | 1.46B | |
+47.62% | 1.42B | |
-28.07% | 1.26B |
- Stock Market
- Equities
- LABS Stock
- News MediPharm Labs Corp.
- MediPharm Labs to Acquire Rights for Advanced Medical Cannabis Products From Remidose Aerosols